Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis
出版年份 2013 全文链接
标题
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis
作者
关键词
-
出版物
ANNALS OF NEUROLOGY
Volume 75, Issue 1, Pages 43-49
出版商
Wiley
发表日期
2013-09-05
DOI
10.1002/ana.24018
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
- (2013) Maria Pia Sormani et al. LANCET NEUROLOGY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis
- (2010) Maria Pia Sormani et al. Multiple Sclerosis Journal
- Surrogate endpoints for EDSS worsening in multiple sclerosis: A meta-analytic approach
- (2010) M. P. Sormani et al. NEUROLOGY
- Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
- (2010) N. De Stefano et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach
- (2009) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
- (2009) Paul O'Connor et al. LANCET NEUROLOGY
- Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
- (2009) Frederik Barkhof et al. Nature Reviews Neurology
- Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
- (2008) Daniel D Mikol et al. LANCET NEUROLOGY
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
- (2008) R. Zivadinov et al. NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started